These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 33507235)

  • 41. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
    Mohammed RN; Tamjidifar R; Rahman HS; Adili A; Ghoreishizadeh S; Saeedi H; Thangavelu L; Shomali N; Aslaminabad R; Marofi F; Tahavvori M; Danshina S; Akbari M; Ercan G
    Cell Commun Signal; 2022 Jun; 20(1):79. PubMed ID: 35655192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.
    Choudhary MC; Crain CR; Qiu X; Hanage W; Li JZ
    Clin Infect Dis; 2022 Jan; 74(2):237-245. PubMed ID: 33906227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor-modified T-cell therapy.
    Gonzalez MA; Bhatti AM; Fitzpatrick K; Boonyaratanakornkit J; Huang ML; Campbell VL; Hecht J; Ibrahimi S; Wanner SN; Green DJ; Maloney DG; Gauthier J; Cowan AJ; Greninger AL; Krantz EM; Koelle DM; Hill JA
    Blood Adv; 2023 May; 7(9):1849-1853. PubMed ID: 36094846
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review.
    Leblanc JF; Germain M; Delage G; OʼBrien S; Drews SJ; Lewin A
    Transfusion; 2020 Dec; 60(12):3046-3054. PubMed ID: 32798237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
    Mollan KR; Eron JJ; Krajewski TJ; Painter W; Duke ER; Morse CG; Goecker EA; Premkumar L; Wolfe CR; Szewczyk LJ; Alabanza PL; Loftis AJ; Degli-Angeli EJ; Brown AJ; Dragavon JA; Won JJ; Keys J; Hudgens MG; Fang L; Wohl DA; Cohen MS; Baric RS; Coombs RW; Sheahan TP; Fischer WA
    Clin Infect Dis; 2022 Aug; 75(1):e1028-e1036. PubMed ID: 35022711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.
    Chu H; Chan JF; Yuen TT; Shuai H; Yuan S; Wang Y; Hu B; Yip CC; Tsang JO; Huang X; Chai Y; Yang D; Hou Y; Chik KK; Zhang X; Fung AY; Tsoi HW; Cai JP; Chan WM; Ip JD; Chu AW; Zhou J; Lung DC; Kok KH; To KK; Tsang OT; Chan KH; Yuen KY
    Lancet Microbe; 2020 May; 1(1):e14-e23. PubMed ID: 32835326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection.
    Chaguza C; Hahn AM; Petrone ME; Zhou S; Ferguson D; Breban MI; Pham K; Peña-Hernández MA; Castaldi C; Hill V; ; Schulz W; Swanstrom RI; Roberts SC; Grubaugh ND
    Cell Rep Med; 2023 Feb; 4(2):100943. PubMed ID: 36791724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
    mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal Assessment of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019.
    Noh JY; Kwak JE; Yang JS; Hwang SY; Yoon JG; Seong H; Hyun H; Lim CS; Yoon SY; Ryou J; Lee JY; Kim SS; Park SH; Cheong HJ; Kim WJ; Shin EC; Song JY
    J Infect Dis; 2021 Sep; 224(5):754-763. PubMed ID: 34467985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Hogan CA; Stevens BA; Sahoo MK; Huang C; Garamani N; Gombar S; Yamamoto F; Murugesan K; Kurzer J; Zehnder J; Pinsky BA
    Clin Infect Dis; 2021 May; 72(9):e291-e295. PubMed ID: 32965474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
    Ge T; Liu H; Wang ZH; Cao Y; Zhang YC; Huang L; Qian WB; Zhou XX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):825-831. PubMed ID: 38049334
    [No Abstract]   [Full Text] [Related]  

  • 55. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
    Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
    Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
    Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines
    Ma MT; Badeti S; Chen CH; Kim J; Choudhary A; Honnen B; Reichman C; Calianese D; Pinter A; Jiang Q; Shi L; Zhou R; Xu H; Li Q; Gause W; Liu D
    Front Immunol; 2021; 12():652223. PubMed ID: 34367128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
    Rocheleau L; Laroche G; Fu K; Stewart CM; Mohamud AO; Côté M; Giguère PM; Langlois MA; Pelchat M
    mBio; 2021 Jun; 12(3):e0078821. PubMed ID: 34182784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.